Varenicline's Neuropsychiatric Safety Concerns AllayedVarenicline's Neuropsychiatric Safety Concerns Allayed

A randomized, placebo-controlled, phase 4 postmarketing study suggests varenicline is effective and safe in patients with stably treated current or past depression. Medscape Medical News

Source: Medscape Psychiatry Headlines - September 17, 2013 Category: Psychiatry Tags: Psychiatry News Source Type: news